WO2023155847A1 - Method and kit for constructing sequencing library for detecting chromosome copy number variation - Google Patents

Method and kit for constructing sequencing library for detecting chromosome copy number variation Download PDF

Info

Publication number
WO2023155847A1
WO2023155847A1 PCT/CN2023/076541 CN2023076541W WO2023155847A1 WO 2023155847 A1 WO2023155847 A1 WO 2023155847A1 CN 2023076541 W CN2023076541 W CN 2023076541W WO 2023155847 A1 WO2023155847 A1 WO 2023155847A1
Authority
WO
WIPO (PCT)
Prior art keywords
dna
polymerase
dna polymerase
endonuclease
activity
Prior art date
Application number
PCT/CN2023/076541
Other languages
French (fr)
Chinese (zh)
Inventor
侯丽敏
陈迪
张建光
张丽
Original Assignee
北京贝瑞和康生物技术有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 北京贝瑞和康生物技术有限公司 filed Critical 北京贝瑞和康生物技术有限公司
Publication of WO2023155847A1 publication Critical patent/WO2023155847A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/06Biochemical methods, e.g. using enzymes or whole viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/06Libraries containing nucleotides or polynucleotides, or derivatives thereof

Definitions

  • the present invention relates to a method for rapidly constructing a high-throughput next-generation sequencing library, in particular, a method for constructing a sequencing library for detecting chromosome copy number variation.
  • CNV Chromosomal copy number variation
  • CNV CNV
  • FISH fluorescence in situ hybridization
  • CMA Chromosome Microarray Analysis
  • qPCR fluorescent quantitative polymerase chain PCR
  • MLPA multiplex ligation probe amplification
  • NGS high-throughput sequencing
  • the first step of library construction is gDNA fragmentation, and the most common implementation methods are physical fragmentation and enzymatic fragmentation.
  • the physical fragmentation method mainly includes ultrasound or confocal acoustic wave (Covaris), which requires special instruments, and has problems such as long time consumption, large amount of gDNA required, and low product recovery efficiency.
  • Enzyme fragmentation most commonly NEBNext DNA double-strand fragmentation enzyme and Tn5 from NEB.
  • the T7 endonuclease in NEBNext DNA double-strand fragmentation enzyme has patent protection, and the fragmented DNA fragments need end repair and A process; the cost of Tn5 library construction is relatively high, and the amount of DNA input and Tn5 must be strictly limited proportion.
  • the above problems can be effectively solved by providing two rapid library construction methods for randomly interrupting gDNA based on different forms of polymerase in the nick translation method for detecting chromosomal copy number variation.
  • a method for constructing a high-throughput sequencing library comprising the following steps:
  • the endonuclease is a Vibrio-derived endonuclease, preferably a Vvn endonuclease derived from Vibrio vulnificus (Vvn).
  • the DNA polymerase is a polymerase single enzyme or a mixed enzyme of the same type of polymerase, which is characterized in that the enzyme has 5'-3' polymerization activity and 5'-3' excision active but does not have 3'-5'exo-cutting activity; preferably, the DNA polymerase is Taq DNA Polymerase; preferably, the reaction temperature in step 2) is fixed, and the temperature range is preferably 40-65°C, more preferably 50- 60°C.
  • the DNA polymerase is a mixture of two types of polymerases, wherein one type of polymerase has 5'-3' polymerization activity and 3'-5' and 5'-3 ' exonucleolytic activity; another polymerase is a polymerase having 5'-3' polymerization activity and 5'-3' exonucleolytic activity but not having 3'-5' exonucleolytic activity; preferably, the Described DNA polymerase is the mixed enzyme of DNA Polymerase I and Taq DNA Polymerase;
  • the reaction temperature of step 2) is variable, first reacts with lower temperature, then reacts with higher reaction temperature, wherein lower The reaction temperature is preferably 30-50°C, more preferably 32-37°C; the higher reaction temperature is preferably 60-75°C, more preferably 68-72°C.
  • steps 2) and 3) are completed in a single reaction tube , no intermediate DNA purification steps are required.
  • the method for constructing a high-throughput sequencing library does not comprise a PCR amplification step.
  • a kit for constructing a high-throughput sequencing library including:
  • the reagents for randomly making nicks and performing nick translation and adding A to the end include endonuclease, DNA polymerase and dNTP.
  • the endonuclease is a Vibrio-derived endonuclease, preferably a Vvn endonuclease derived from Vibrio vulnificus (Vvn).
  • the DNA polymerase is a polymerase single enzyme or a mixed enzyme of the same type of polymerase, which is characterized in that the enzyme has 5'-3' polymerization activity and 5'-3' excision Activity but no 3'-5' exoactivity; preferably, the DNA polymerase is Taq DNA Polymerase.
  • the DNA polymerase is a mixture of two types of polymerases, wherein one type of polymerase has 5'-3' polymerization activity and 3'-5' and 5'-3 ' exonucleolytic activity; another polymerase is a polymerase having 5'-3' polymerization activity and 5'-3' exonucleolytic activity but not having 3'-5' exonucleolytic activity; preferably, the The DNA polymerase is a mixed enzyme of DNA Polymerase I and Taq DNA Polymerase.
  • the reagent for ligating the A-added DNA fragments to the sequencing adapters includes ligase.
  • the ligase is T4 DNA ligase or T7 DNA ligase.
  • the reagents for purifying the ligated product are selected from purification columns, Qiagen columns, purification magnetic beads or Beckman Ampure XP beads
  • Figure 1 Schematic diagram of the principle of the method of the present invention.
  • Figure 2 Schematic diagram of the library construction method of the present invention.
  • Figure 3 Gel diagram for determining the amount of Vvn endonuclease, where gDNA: genome control, no interruption reaction; VVn-negative: negative control, except for VVn, the rest of the reactants were added to the reaction system for interruption reaction; VVn -10 0 , 10 -1 , 10 -2 , 10 -3 , 10 - 4 : represent adding 1.0uL of VVn stock solution, 10-fold dilution, 100-fold dilution, 1000-fold dilution, 10000-fold dilution to the system respectively, and the rest The reaction product of the reactants.
  • M Marker.
  • Figure 4 Gel map for determining the amount of Taq DNA Polymerase, where 0.25, 0.5, 1.0, 2.0: represent the volume of Taq DNA Polymerase added in the reaction system is 0.25uL, 0.5uL, 1.0uL, 2.0uL, and the rest of the reactants are added Reaction product; M: Marker.
  • Figures 5a-5k results of sequencing the aneuploid samples of different chromosomes after constructing the library using the method of the present invention.
  • Figure 6 The results of sequencing different chromosomal microdeletion syndrome samples after library construction using the method of the present invention, where the ordinate refers to the copy number of the detection region, and the abscissa represents the entire chromosome region.
  • the entire chromosome is evenly divided into several regions, and each point represents the copy number of a region, and then a trend line (blue solid line) is obtained according to the distribution of all points.
  • the red box in the figure lists the region of microdeletion in each sample.
  • Sequence analysis refers to determining the order of nucleotides (base sequence) in a nucleic acid sample such as DNA or RNA.
  • High-throughput sequencing is also called “next generation sequencing”, or NGS for short. It refers to the sequence determination of hundreds of thousands to millions of DNA molecules at a time.
  • “Nick translation” refers to the 5'-3' exonuclease activity of a DNA molecule with a cut under the action of DNA polymerase (with 5'-3' exonuclease activity and 5'-3' polymerase activity). It can hydrolyze the DNA strand from the 5' end of the nick, and at the same time, its polymerization activity extends the DNA strand at the nick to the 3' end, resulting in the translation of the nick position from the 5' end to the 3' end. This method is commonly used to introduce radiolabeled nucleotides into DNA molecules.
  • the prior art lacks new and effective fragmentation techniques and rapid library construction methods that can be used to detect chromosomal copy number variations.
  • a method for a library comprising the steps of:
  • the content of the starting DNA in the sample can be those routinely used in the art, for example, it can be 3.5ng-1000ng.
  • the endonuclease there is no particular limitation, and those conventionally used in the art may be used.
  • the endonuclease is a Vibrio-derived endonuclease, more preferably a Vvn endonuclease derived from halophilic Vibrio (Vibrio vulnificus) (Vvn).
  • the endonuclease can also be a wild-type Vvn endonuclease or a mutant thereof.
  • the DNA polymerase there is no particular limitation, and those conventionally used in the art may be used. However, preferably, the DNA polymerase can be used in one of the following two ways.
  • the DNA polymerase is a single polymerase or the same type of polymerase Mixed enzymes of synthases, characterized in that the enzymes have 5'-3' polymerization activity and 5'-3' exo-cleavage activity but no 3'-5' exo-cleavage activity.
  • the DNA polymerase used in this first approach is Taq DNA Polymerase.
  • the reaction temperature in step 2) is fixed, and the temperature range is preferably 40-65°C, more preferably 50-60°C.
  • Vvn endonuclease a combination of the above-mentioned Vvn endonuclease and Taq DNA Polymerase is used to carry out the above step 2), so that the Vvn endonuclease randomly generates a single-stranded nick on the double-stranded DNA, and Taq DNA Polymerase uses this nick from The 5' end is translated to the 3' end to achieve random fragmentation of DNA and add A.
  • the amount of Vvn used in the step (2) is 0.11ug-1.1ug, preferably 0.33ug-1.1ug, more preferably 0.88ug.
  • the usage activity unit amount of Taq DNA Polymerase in the step (2) is 1.25U ⁇ 5U, preferably 1.25U ⁇ 2.5U, More preferably 1.25U.
  • the reaction conditions of the step (1) can be: 45°C-68°C, 20 minutes, preferably the reaction temperature is 50°C-62°C, more preferably 50°C or 60°C.
  • the reaction temperature is 50°C-62°C, more preferably 50°C or 60°C.
  • the DNA polymerase is a mixture of two types of polymerases, one of which has 5'-3' polymerization activity and 3'-5' and 5'-3' Exonucleolytic activity; another polymerase is a polymerase that has 5'-3' polymerization activity and 5'-3' exonucleolytic activity but does not have 3'-5' exonucleolytic activity.
  • the DNA polymerase used in the second mode is a mixed enzyme of DNA Polymerase I and Taq DNA Polymerase.
  • the reaction temperature of step 2) is variable, first react at a lower temperature, and then react at a higher reaction temperature, wherein the lower reaction temperature is preferably 30-50°C, more preferably Preferably 32-37°C, such as 30°C, 31°C, 32°C, 33°C, 34°C, 35°C, 36°C, 37°C, 38°C, 39°C, 40°C, 41°C, 42°C, 43°C , 44°C, 45°C, 46°C, 47°C, 48°C, 49°C, 50°C or any value between these values; the higher reaction temperature is preferably 60-75°C, more preferably 68-72°C, for example can be 60°C, 61°C, 62°C, 63°C, 64°C, 65°C, 66°C, 67°C, 68°C, 69°C, 70°C, 71°C, 72°C, 73°C, 74°C, 75°C
  • the reaction conditions of step 2) can be: 37°C for 5min-20min; 68°C for 10min, preferably 37°C for 5min-10min; 68°C for 10min, more preferably 37°C for 10min; 68°C for 10min.
  • Vvn endonuclease+DNA Polymerase I+Taq DNA Polymerase to carry out the above step 2), the Vvn randomly generates a single-stranded nick on the double-stranded DNA, and DNA Polymerase I uses this nick from the 5' The end is translated to the 3' end to realize random fragmentation of DNA, and Taq DNA Polymerase realizes the addition of A to fragmented DNA.
  • the amount of Vvn used in the step (2) is 0.011ug-0.11ug, preferably 0.033ug-0.11ug, more preferably 0.088ug.
  • the amount of DNA Polymerase I used in the step (2) is 3.2U to 10U, preferably 3.2U to 10U, more preferably 3.2U, for example, 3.20U, 3.25U, 3.25U, 3.30U, 3.35U, 3.40U, 3.45U, 3.50U, 3.55U, 3.60U, 3.65U, 3.70U, 3.75U, 3.80U, 3.85U, 3.90U, 3.95U, 4.0U, 4.05U, 4.10U, 4.15U, 4.20U , 4.25U, 4.30U, 4.35U, 4.40U, 4.45U, 4.50U, 4.55U, 4.60U, 4.65U, 4.70U, 4.75U, 4.80U, 4.85U, 4.90U, 4.95U, 5.0U, 5.20 U, 5.25U, 5.30U, 5.35U, 5.40U, 5.45U, 5.50U, 5.55U, 5.60U, 5.65U, 5.70U, 5.75U, 5.80U, 5.85U
  • the use activity unit amount of Taq DNA Polymerase in the step (2) is 1.25U ⁇ 5U, preferably 1.25U ⁇ 2.5U, more preferably 1.25U, for example, 1.25U can be specifically selected , 1.30U, 1.35U, 1.40U, 1.45U, 1.50U, 1.55U, 1.60U, 1.65U, 1.70U, 1.75U, 1.80U, 1.85U, 1.90U, 1.95U, 2.0U, 2.05U, 2.10 U, 2.15U, 2.20U, 2.25U, 2.30U, 2.35U, 2.40U, 2.45U, 2.50U, 2.55U, 2.60U, 2.65U, 2.70U, 2.75U, 2.80U, 2.85U, 2.90U, 2.95U, 3.0U, 3.05U, 3.10U, 3.15U, 3.20U, 3.25U, 3.30U, 3.35U, 3.40U, 3.45U, 3.50U, 3.55U, 3.60U, 3.65U, 3.70U, 3..
  • steps 2) and 3) in the method of the first exemplary embodiment of the present invention it can be done in a single reaction tube without the need for a DNA purification step in between.
  • it may not comprise a PCR amplification step.
  • a kit for constructing a high-throughput sequencing library comprising:
  • reagents for randomly nicking, nick translation and end-adding include endonucleases, DNA polymerases and dNTPs.
  • the endonuclease there is no particular limitation, and those conventionally used in the art may be used.
  • the endonuclease is a Vibrio-derived endonuclease, more preferably a Vvn endonuclease derived from halophilic Vibrio (Vibrio vulnificus) (Vvn).
  • the endonuclease can also be a wild-type Vvn endonuclease or a mutant thereof.
  • the DNA polymerase there is no particular limitation, and those conventionally used in the art may be used. However, preferably, the DNA polymerase can be used in one of the following two ways.
  • the DNA polymerase is a polymerase single enzyme or a mixed enzyme of the same type of polymerase, which is characterized in that the enzyme has 5'-3' polymerization activity and 5'-3' excision activity But it does not have 3'-5'exo-cutting activity.
  • the DNA polymerase used in this first approach is Taq DNA Polymerase.
  • the DNA polymerase is a mixture of two types of polymerases, one of which has 5'-3' polymerization activity and 3'-5' and 5'-3' Exonucleolytic activity; another polymerase is a polymerase that has 5'-3' polymerization activity and 5'-3' exonucleolytic activity but does not have 3'-5' exonucleolytic activity.
  • the DNA polymerase used in the second mode is a mixed enzyme of DNA Polymerase I and Taq DNA Polymerase.
  • the reagents for ligating the A-added DNA fragments to the sequencing adapters are not particularly limited, and may be those routinely used in the art. However, preferably, the reagent for ligating the A-added DNA fragments to the sequencing adapters includes ligase.
  • the ligase there is no particular limitation, and those conventionally used in the art may be used. However, preferably, the ligase is T4 DNA ligase or T7 DNA ligase.
  • the reagents used to purify the ligation product there are no particular limitations on the reagents used to purify the ligation product, and may be those routinely used in the art. However, preferably, the reagents for purifying the ligated product are selected from purification columns, Qiagen columns, purification magnetic beads or Beckman Ampure XP beads.
  • Embodiment 1 Determining the input amount of VVn endonuclease.
  • VVn includes no addition (negative control), stock solution (10 0 ), 10 -1 , 10 -2 , 10 -3 , 10 -4 6 gradients.
  • Embodiment 2 Determine the input amount of Taq DNA Polymerase.
  • reaction program of the PCR instrument was set as 37°C for 20 minutes; 68°C for 20 minutes; 4°C forever.
  • the input amount of Taq DNA Polymerase is 0.25uL (ie 1.25U) and 0.5
  • uL (ie 2.5U) the size of the library is 300bp, and the scatter is small;
  • the input amount of Taq DNA Polymerase is 1.0uL and 2.0uL, the library scatter is serious, and there are large fragments that are not interrupted.
  • Embodiment 3 Determine the reaction temperature of VVn endonuclease and Taq DNA Polymerase.
  • reaction program of the PCR instrument was set at 45°C ⁇ 68°C for 20 minutes; 4°C forever with a total of 9 temperature gradients.
  • On-machine sequencing use the NextSeq CN500 (National Machinery Note 20153400460) sequencer to perform on-machine sequencing according to the manufacturer's instructions.
  • Example 4 Effect of DNA starting content on sequencing library concentration.
  • Example 5 Detection verification of different aneuploid samples.
  • Example 6 A mixture of VVn and two types of polymerases achieves random fragmentation of DNA.
  • reaction program of the PCR instrument was set as 37°C for 10 minutes (5 minutes); 68°C for 10 minutes; 4°C forever, a total of 2 temperature gradients.
  • On-machine sequencing use the NextSeq CN500 (National Machinery Note 20153400460) sequencer to perform on-machine sequencing according to the manufacturer's instructions.
  • Example 7 The mixed enzyme of VVn and two types of polymerases realizes the random fragmentation of DNA and detects chromosome microdeletion syndrome.
  • Example 6 According to the experimental conditions determined in Example 6, three DNA samples of chromosome microdeletion syndrome were used to construct a library for detection of DNA copy number variation of chromosome microdeletion. The sequencing results were compared with the reference sequence of the human genome. The detection results of different DNA samples using this method are shown in Table 10 and Figure 6 below. Abnormalities in the DNA copy number in the corresponding regions can be detected correctly.
  • Example 8 VVn endonuclease+Taq DNA Polymerase realizes random fragmentation of RNA/DNA hybrid double strands.
  • the library was constructed according to the experimental conditions determined in the above-mentioned Example 3 (VVn was diluted 10 times into 8uL, Taq DNA Polymerase into 0.25uL, and the reaction temperature was 60°C).
  • the method for constructing a high-throughput sequencing library of the present invention provides a new and effective fragmentation technology and a rapid library construction method, which can more efficiently construct a sequencing library for detecting chromosome copy number variation, and obtain Obvious beneficial technical effects have been achieved.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Provided are a method and kit for constructing a sequencing library for detecting chromosome copy number variation. The method comprises the following steps: 1) providing a genome DNA or RNA/DNA hybrid double-strand sample; 2) adding endonuclease and DNA polymerase into the sample, randomly shearing DNA double strands or RNA/DNA hybrid double strands by means of the nick translation principle to obtain a DNA fragment, and adding A at the tail end of the fragment to obtain an A-added DNA fragment; 3) performing ligation on the A-added DNA fragment and a sequencing adapter to obtain a ligation product; and 4) purifying the ligation product to obtain a sequencing library. The kit comprises: 1) a reagent for performing random nicking and performing nick translation and A-addition at a tail end; 2) a reagent for ligation of the A-added DNA fragment and a sequencing adapter; and 3) a reagent for purifying the ligation product.

Description

用于构建检测染色体拷贝数变异的测序文库的方法和试剂盒Methods and kits for constructing sequencing libraries for detection of chromosomal copy number variation 技术领域technical field
本发明涉及快速构建高通量二代测序文库的方法,具体地,涉及用于构建检测染色体拷贝数变异的测序文库的方法。The present invention relates to a method for rapidly constructing a high-throughput next-generation sequencing library, in particular, a method for constructing a sequencing library for detecting chromosome copy number variation.
背景技术Background technique
染色体拷贝数变异(CNV)是人类遗传变异的一种重要形式,在人类基因组中广泛分布,其覆盖染色体范围广,突变频率高,可导致突变个体的表型发生严重改变甚至使突变个体死亡。Chromosomal copy number variation (CNV) is an important form of human genetic variation. It is widely distributed in the human genome. It covers a wide range of chromosomes and has a high mutation frequency. It can lead to severe changes in the phenotype of mutant individuals and even the death of mutant individuals.
目前,检测CNV的技术包括传统核型分析技术(Karyotyping)结合荧光原位杂交(FISH)、染色体微列阵分析技术(Chromosome Microarray Analysis,CMA,如aCGH和SNP-array)、荧光定量聚合酶链式反应(qPCR)、多重连接探针扩增技术(MLPA)、高通量测序技术(NGS)等(Nord,et al,2015;Manning and Hudgins,2010;Trask,1991;)。近些年日益成熟的NGS因其通量高、准确性高、灵敏性高、自动化程度高和运行成本低等突出的优势,使其在临床研究中得到广泛的应用(Xuan,et al,2013)。Currently, techniques for detecting CNV include traditional karyotyping combined with fluorescence in situ hybridization (FISH), Chromosome Microarray Analysis (CMA, such as aCGH and SNP-array), fluorescent quantitative polymerase chain PCR (qPCR), multiplex ligation probe amplification (MLPA), high-throughput sequencing (NGS), etc. (Nord, et al, 2015; Manning and Hudgins, 2010; Trask, 1991;). In recent years, the increasingly mature NGS has been widely used in clinical research due to its outstanding advantages such as high throughput, high accuracy, high sensitivity, high degree of automation and low operating cost (Xuan, et al, 2013 ).
在NGS现有的建库技术中,建库的第一步是gDNA片段化,最常见的实现方式是物理打断和酶打断。物理打断法主要包括超声或者声波共聚焦(Covaris),需要特殊仪器,并且存在用时长,gDNA需要量大,产物回收效率低等问题。酶打断,最常见的是NEB的NEBNext DNA双链片段化酶和Tn5。NEBNext DNA双链片段化酶中的T7核酸内切酶具有专利保护,且片段化后的DNA片段需末端修复和加A过程;Tn5建库成本相对较高,而且必须严格限制DNA投入量和Tn5的比例。In the existing library construction technology of NGS, the first step of library construction is gDNA fragmentation, and the most common implementation methods are physical fragmentation and enzymatic fragmentation. The physical fragmentation method mainly includes ultrasound or confocal acoustic wave (Covaris), which requires special instruments, and has problems such as long time consumption, large amount of gDNA required, and low product recovery efficiency. Enzyme fragmentation, most commonly NEBNext DNA double-strand fragmentation enzyme and Tn5 from NEB. The T7 endonuclease in NEBNext DNA double-strand fragmentation enzyme has patent protection, and the fragmented DNA fragments need end repair and A process; the cost of Tn5 library construction is relatively high, and the amount of DNA input and Tn5 must be strictly limited proportion.
因此,寻找新型有效的片段化技术和快速的建库方法用于检测染色体拷贝数变异,意义重大。 Therefore, it is of great significance to find new and effective fragmentation techniques and rapid library construction methods for detecting chromosomal copy number variation.
发明内容Contents of the invention
通过基于切口平移法中聚合酶的不同形式提供两种随机打断gDNA的快速建库方法以用于检测染色体拷贝数变异,可以有效解决上述问题。The above problems can be effectively solved by providing two rapid library construction methods for randomly interrupting gDNA based on different forms of polymerase in the nick translation method for detecting chromosomal copy number variation.
根据本发明的第一方面,提供用于构建高通量测序文库的方法,包括以下步骤:According to a first aspect of the present invention, a method for constructing a high-throughput sequencing library is provided, comprising the following steps:
1)提供基因组DNA或RNA/DNA杂合双链样品;1) Provide genomic DNA or RNA/DNA hybrid double-stranded samples;
2)向上述样品中加入核酸内切酶和DNA聚合酶,利用切口平移原理将DNA双链或RNA/DNA杂合双链随机打断得到DNA片段并在片段末端加A,以得到加A后的DNA片段;2) Add endonuclease and DNA polymerase to the above sample, use the principle of nick translation to randomly interrupt the DNA double strand or RNA/DNA hybrid double strand to obtain DNA fragments, and add A to the end of the fragment to obtain the A-added DNA fragments;
3)将所述加A后的DNA片段与测序接头连接获得连接产物;3) Ligate the A-added DNA fragments with a sequencing adapter to obtain a ligation product;
4)纯化所述连接产物,获得测序文库。4) purifying the ligation product to obtain a sequencing library.
在一种优选实施方案中,所述核酸内切酶是源自弧菌的核酸内切酶,优选源自嗜盐弧菌(Vibrio vulnificus)(Vvn)的Vvn核酸内切酶。In a preferred embodiment, the endonuclease is a Vibrio-derived endonuclease, preferably a Vvn endonuclease derived from Vibrio vulnificus (Vvn).
在一种优选实施方案中,所述DNA聚合酶是聚合酶单酶或同种类型聚合酶的混合酶,其特点是所述酶具有5′-3′聚合活性和5′-3′外切活性但不具有3′-5′外切活性;优选地,所述DNA聚合酶是Taq DNA Polymerase;优选地,其中步骤2)的反应温度固定,温度范围优选40-65℃,更优选50-60℃。In a preferred embodiment, the DNA polymerase is a polymerase single enzyme or a mixed enzyme of the same type of polymerase, which is characterized in that the enzyme has 5'-3' polymerization activity and 5'-3' excision active but does not have 3'-5'exo-cutting activity; preferably, the DNA polymerase is Taq DNA Polymerase; preferably, the reaction temperature in step 2) is fixed, and the temperature range is preferably 40-65°C, more preferably 50- 60°C.
在一种优选实施方案中,所述DNA聚合酶是两种类型聚合酶的混合酶,其中一种类型的聚合酶是具有5′-3′聚合活性以及3′-5′和5′-3′核酸外切活性;另一种聚合酶是具有5′-3′聚合活性和5′-3′核酸外切活性但不具有3′-5′核酸外切活性的聚合酶;优选地,所述DNA聚合酶是DNA Polymerase I和Taq DNA Polymerase的混合酶;优选地,其中步骤2)的反应温度是可变的,先用较低温度反应,再用较高的反应温度反应,其中较低反应温度优选30-50℃,更优选32-37℃;较高反应温度优选60-75℃,更优选68-72℃。In a preferred embodiment, the DNA polymerase is a mixture of two types of polymerases, wherein one type of polymerase has 5'-3' polymerization activity and 3'-5' and 5'-3 ' exonucleolytic activity; another polymerase is a polymerase having 5'-3' polymerization activity and 5'-3' exonucleolytic activity but not having 3'-5' exonucleolytic activity; preferably, the Described DNA polymerase is the mixed enzyme of DNA Polymerase I and Taq DNA Polymerase; Preferably, wherein the reaction temperature of step 2) is variable, first reacts with lower temperature, then reacts with higher reaction temperature, wherein lower The reaction temperature is preferably 30-50°C, more preferably 32-37°C; the higher reaction temperature is preferably 60-75°C, more preferably 68-72°C.
在一种优选实施方案中,其中步骤2)和3)在单一反应管中完 成,中间不需要DNA纯化步骤。In a preferred embodiment, wherein steps 2) and 3) are completed in a single reaction tube , no intermediate DNA purification steps are required.
在一种优选实施方案中,所述用于构建高通量测序文库的方法不包含PCR扩增步骤。In a preferred embodiment, the method for constructing a high-throughput sequencing library does not comprise a PCR amplification step.
在一种优选实施方案中,其中所述文库用于检测染色体拷贝数变异。In a preferred embodiment, wherein said library is used to detect chromosomal copy number variation.
根据本发明的第二方面,提供用于构建高通量测序文库的试剂盒,包括:According to a second aspect of the present invention, a kit for constructing a high-throughput sequencing library is provided, including:
1)随机打切口并进行切口平移和末端加A的试剂;1) Make random cuts and perform cut translation and add A reagent at the end;
2)将所述加A后的DNA片段与测序接头连接的试剂;和2) a reagent for ligating the A-added DNA fragment with a sequencing adapter; and
3)用于纯化所述连接产物的试剂。3) Reagents for purifying the ligated product.
在一种优选实施方案中,所述随机打切口并进行切口平移和末端加A的试剂包括核酸内切酶,DNA聚合酶和dNTP。In a preferred embodiment, the reagents for randomly making nicks and performing nick translation and adding A to the end include endonuclease, DNA polymerase and dNTP.
在一种优选实施方案中,所述核酸内切酶是源自弧菌的核酸内切酶,优选源自嗜盐弧菌(Vibrio vulnificus)(Vvn)的Vvn核酸内切酶。In a preferred embodiment, the endonuclease is a Vibrio-derived endonuclease, preferably a Vvn endonuclease derived from Vibrio vulnificus (Vvn).
在一种优选实施方案中,所述DNA聚合酶是聚合酶单酶或同种类型聚合酶的混合酶,其特点是所述酶具有5′-3′聚合活性和5′-3′外切活性但不具有3′-5′外切活性;优选地,所述DNA聚合酶是Taq DNA Polymerase。In a preferred embodiment, the DNA polymerase is a polymerase single enzyme or a mixed enzyme of the same type of polymerase, which is characterized in that the enzyme has 5'-3' polymerization activity and 5'-3' excision Activity but no 3'-5' exoactivity; preferably, the DNA polymerase is Taq DNA Polymerase.
在一种优选实施方案中,所述DNA聚合酶是两种类型聚合酶的混合酶,其中一种类型的聚合酶是具有5′-3′聚合活性以及3′-5′和5′-3′核酸外切活性;另一种聚合酶是具有5′-3′聚合活性和5′-3′核酸外切活性但不具有3′-5′核酸外切活性的聚合酶;优选地,所述DNA聚合酶是DNA Polymerase I和Taq DNA Polymerase的混合酶。In a preferred embodiment, the DNA polymerase is a mixture of two types of polymerases, wherein one type of polymerase has 5'-3' polymerization activity and 3'-5' and 5'-3 ' exonucleolytic activity; another polymerase is a polymerase having 5'-3' polymerization activity and 5'-3' exonucleolytic activity but not having 3'-5' exonucleolytic activity; preferably, the The DNA polymerase is a mixed enzyme of DNA Polymerase I and Taq DNA Polymerase.
在一种优选实施方案中,将所述加A后的DNA片段与测序接头连接的试剂包括连接酶。In a preferred embodiment, the reagent for ligating the A-added DNA fragments to the sequencing adapters includes ligase.
在一种优选实施方案中,所述连接酶是T4 DNA连接酶或者T7 DNA连接酶。 In a preferred embodiment, the ligase is T4 DNA ligase or T7 DNA ligase.
在一种优选实施方案中,所述用于纯化所述连接产物的试剂选自纯化柱、Qiagen柱、纯化磁珠或者Beckman Ampure XP beadsIn a preferred embodiment, the reagents for purifying the ligated product are selected from purification columns, Qiagen columns, purification magnetic beads or Beckman Ampure XP beads
应当理解,本部分所描述的内容并非旨在标识本发明的实施例的关键或重要特征,也不用于限制本发明的范围。本发明的其它特征将通过以下的说明书而变得容易理解。It should be understood that the content described in this section is not intended to identify key or important features of the embodiments of the present invention, nor is it intended to limit the scope of the present invention. Other features of the present invention will be easily understood from the following description.
附图说明Description of drawings
图1:本发明所述方法的原理示意图。Figure 1: Schematic diagram of the principle of the method of the present invention.
图2:本发明所述文库构建方法的示意图。Figure 2: Schematic diagram of the library construction method of the present invention.
图3:确定Vvn核酸内切酶用量胶图,其中gDNA:基因组对照,未进行打断反应;VVn-阴:阴性对照,反应体系中除VVn外,其余反应物均加入进行打断反应;VVn-100、10-1、10-2、10-3、10- 4:代表体系中分别加入VVn的原液、稀释10倍、稀释100倍、稀释1000倍、稀释10000倍各1.0uL,与其余反应物的反应产物。M:Marker。Figure 3: Gel diagram for determining the amount of Vvn endonuclease, where gDNA: genome control, no interruption reaction; VVn-negative: negative control, except for VVn, the rest of the reactants were added to the reaction system for interruption reaction; VVn -10 0 , 10 -1 , 10 -2 , 10 -3 , 10 - 4 : represent adding 1.0uL of VVn stock solution, 10-fold dilution, 100-fold dilution, 1000-fold dilution, 10000-fold dilution to the system respectively, and the rest The reaction product of the reactants. M: Marker.
图4:确定Taq DNA Polymerase用量胶图,其中0.25、0.5、1.0、2.0:代表反应体系中Taq DNA Polymerase加入的体积分别是0.25uL、0.5uL、1.0uL、2.0uL,其余反应物均加入的反应产物;M:Marker。Figure 4: Gel map for determining the amount of Taq DNA Polymerase, where 0.25, 0.5, 1.0, 2.0: represent the volume of Taq DNA Polymerase added in the reaction system is 0.25uL, 0.5uL, 1.0uL, 2.0uL, and the rest of the reactants are added Reaction product; M: Marker.
图5a-5k:采用本发明的方法构建文库后对不同染色体非整倍体样本进行测序的结果图。Figures 5a-5k: results of sequencing the aneuploid samples of different chromosomes after constructing the library using the method of the present invention.
图6:采用本发明的方法构建文库后对不同染色体微缺失综合征样本进行测序的结果图,其中纵坐标是指检测区域的拷贝数,横坐标代表整条染色体区域。其中整条染色体被均匀地分成若干个区域,每个点代表一个区域的拷贝数,然后根据所有点的分布得到趋势线(蓝色实线)。图中红色框列出了每一个样本染色体微缺失的区域。Figure 6: The results of sequencing different chromosomal microdeletion syndrome samples after library construction using the method of the present invention, where the ordinate refers to the copy number of the detection region, and the abscissa represents the entire chromosome region. The entire chromosome is evenly divided into several regions, and each point represents the copy number of a region, and then a trend line (blue solid line) is obtained according to the distribution of all points. The red box in the figure lists the region of microdeletion in each sample.
具体实施方式 Detailed ways
下面将更详细地描述本发明的实施例。然而,应当理解的是,本发明可以通过各种形式来实现,而且不应该被解释为限于这里阐述的实施例,相反提供这些实施例是为了更加透彻和完整地理解本发明。还应当理解的是,本发明的附图及实施例仅用于示例性作用,并非用于限制本发明的保护范围。Embodiments of the present invention will be described in more detail below. It should be understood, however, that the invention may be embodied in various forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided for a more thorough and complete understanding of this invention. It should also be understood that the drawings and embodiments of the present invention are for exemplary purposes only, and are not intended to limit the protection scope of the present invention.
除非另有限定,本文使用的所有技术以及科学术语具有与本发明所属领域普通技术人员通常理解的相同的含义。当存在矛盾时,以本说明书中的定义为准。Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In case of conflict, the definitions in this specification shall prevail.
本文中所用的术语“包含”、“包括”、“具有”、“含有”或其任何其它变形,意在覆盖非排它性的包括。As used herein, the terms "comprises," "including," "has," "containing," or any other variation thereof, are intended to cover a non-exclusive inclusion.
当量、浓度、或其它值或参数以范围、优选范围、或一系列上限优选值和下限优选值限定的范围表示时,这应当被理解为具体公开了由任何范围上限或优选值与任何范围下限或优选值的任一配对所形成的所有范围,而不论该范围是否单独公开了。例如,当公开了范围“1至5”时,所描述的范围应被解释为包括范围“1至4”、“1至3”、“1-2”、“1-2和4-5”、“1-3和5”等。当数值范围在本文中被描述时,除非另外说明,否则该范围意图包括其端值和在该范围内的所有整数和分数。When amounts, concentrations, or other values or parameters are expressed in terms of ranges, preferred ranges, or ranges bounded by a series of upper preferred values and lower preferred values, it is to be understood that any range upper or preferred value combined with any lower range limit All ranges formed by any pairing of values or preferred values, whether or not such ranges are individually disclosed. For example, when the range "1 to 5" is disclosed, the recited range should be construed to include the ranges "1 to 4," "1 to 3," "1-2," "1-2, and 4-5" , "1-3 and 5", etc. When a numerical range is described herein, unless otherwise stated, that range is intended to include its endpoints and all integers and fractions within the range.
此外,本文中要素或组分前的不定冠词“一种”和“一个”对要素或组分的数量要求(即出现次数)无限制性。因此“一个”或“一种”应被解读为包括一个或至少一个,并且单数形式的要素或组分也包括复数形式,除非所述数量明显旨在限定单数形式。Furthermore, the indefinite articles "a" and "an" preceding an element or component herein place no limitation on the quantity requirement (ie, number of occurrences) of the element or component. Thus "a" or "an" should be read to include one or at least one, and elements or components in the singular include the plural unless it is obvious that the number stated is intended to limit the singular.
进一步地,在以下说明书中将提及大量的表述,这些表述被定义为具有下列含义。Further, in the following specification, a large number of expressions will be mentioned, which are defined to have the following meanings.
“测序”是指测定在核酸样品例如DNA或RNA中的核苷酸(碱基序列)的顺序。"Sequencing" refers to determining the order of nucleotides (base sequence) in a nucleic acid sample such as DNA or RNA.
“高通量测序”又称为“下一代测序技术(next generation sequencing)”,简称NGS。是指一次对几十万到几百万条DNA分子进行序列测定。 "High-throughput sequencing" is also called "next generation sequencing", or NGS for short. It refers to the sequence determination of hundreds of thousands to millions of DNA molecules at a time.
“切口平移”是指一个具有切口的DNA分子在DNA聚合酶(具有5′-3′外切酶活性和5′-3′聚合酶活性)的作用下,5′-3′外切酶活性能从切口的5′端水解DNA链,同时其聚合活性在切口处向3′端延伸DNA链,结果导致切口位置从5′端向3′端平移。该方法通常用于向DNA分子引入放射性标记核苷酸。"Nick translation" refers to the 5'-3' exonuclease activity of a DNA molecule with a cut under the action of DNA polymerase (with 5'-3' exonuclease activity and 5'-3' polymerase activity). It can hydrolyze the DNA strand from the 5' end of the nick, and at the same time, its polymerization activity extends the DNA strand at the nick to the 3' end, resulting in the translation of the nick position from the 5' end to the 3' end. This method is commonly used to introduce radiolabeled nucleotides into DNA molecules.
如前文所描述,现有技术中缺乏可以用于检测染色体拷贝数变异的新型有效的片段化技术和快速的建库方法。As described above, the prior art lacks new and effective fragmentation techniques and rapid library construction methods that can be used to detect chromosomal copy number variations.
用于构建高通量测序文库的方法Methods for Construction of High-Throughput Sequencing Libraries
为了至少部分地解决上述问题以及其他潜在问题中的一个或者多个,参见图1(原理示意)和图2(总体方法示意),本发明的第一示例实施方案提出用于构建高通量测序文库的方法,包括以下步骤:In order to at least partially address one or more of the above-mentioned problems and other potential problems, referring to Fig. A method for a library comprising the steps of:
1)提供基因组DNA或RNA/DNA杂合双链样品;1) Provide genomic DNA or RNA/DNA hybrid double-stranded samples;
2)向上述样品中加入核酸内切酶和DNA聚合酶,利用切口平移原理将DNA双链或RNA/DNA杂合双链随机打断得到DNA片段并在片段末端加A,以得到加A后的DNA片段;2) Add endonuclease and DNA polymerase to the above sample, use the principle of nick translation to randomly interrupt the DNA double strand or RNA/DNA hybrid double strand to obtain DNA fragments, and add A to the end of the fragment to obtain the A-added DNA fragments;
3)将所述加A后的DNA片段与测序接头连接获得连接产物;3) Ligate the A-added DNA fragments with a sequencing adapter to obtain a ligation product;
4)纯化所述连接产物,获得测序文库。4) purifying the ligation product to obtain a sequencing library.
关于样品中起始DNA的含量,并无特别限制,可以为本领域中常规使用的那些,例如可以为3.5ng-1000ng。There is no particular limitation on the content of the starting DNA in the sample, and it can be those routinely used in the art, for example, it can be 3.5ng-1000ng.
关于核酸内切酶,并无特别限制,可以为本领域中常规使用的那些。但是,优选地,所述核酸内切酶是源自弧菌的核酸内切酶,更优选源自嗜盐弧菌(Vibrio vulnificus)(Vvn)的Vvn核酸内切酶。进一步地,所述核酸内切酶还可以是Vvn核酸内切酶的野生型或其突变体。As for the endonuclease, there is no particular limitation, and those conventionally used in the art may be used. However, preferably, the endonuclease is a Vibrio-derived endonuclease, more preferably a Vvn endonuclease derived from halophilic Vibrio (Vibrio vulnificus) (Vvn). Further, the endonuclease can also be a wild-type Vvn endonuclease or a mutant thereof.
关于DNA聚合酶,并无特别限制,可以为本领域中常规使用的那些。但是,优选地,所述DNA聚合酶可以采用下述两种方式之一使用。As for the DNA polymerase, there is no particular limitation, and those conventionally used in the art may be used. However, preferably, the DNA polymerase can be used in one of the following two ways.
在第一种方式中,所述DNA聚合酶是聚合酶单酶或同种类型聚 合酶的混合酶,其特点是所述酶具有5′-3′聚合活性和5′-3′外切活性但不具有3′-5′外切活性。优选地,在该第一种方式中使用的DNA聚合酶是Taq DNA Polymerase。优选地,在该第一种方式中,步骤2)的反应温度固定,温度范围优选40-65℃,更优选50-60℃。例如,可以具体选择40℃、41℃、42℃、43℃、44℃、45℃、46℃、47℃、48℃、49℃、50℃、51℃、52℃、53℃、54℃、55℃、56℃、57℃、58℃、59℃、60℃或这些数值之间的任何数值。进一步优选地,使用上述Vvn核酸内切酶和Taq DNA Polymerase的组合来进行上述步骤2),使得所述Vvn核酸内切酶随机在双链DNA上产生单链切口,Taq DNA Polymerase以此切口从5′端向3′端平移,实现DNA的随机片段化并加A。使用此组合时,典型地,所述步骤(2)的Vvn的使用量是0.11ug-1.1ug,优选为0.33ug-1.1ug,进一步优选为0.88ug。例如,可以具体选择0.11ug、0.12ug、0.13ug、0.14ug、0.15ug、0.16ug、0.17ug、0.18ug、0.19ug、0.20ug、0.21ug、0.22ug、0.23ug、0.24ug、0.25ug、0.26ug、0.27ug、0.28ug、0.29ug、0.30ug、0.31ug、0.32ug、0.33ug、0.34ug、0.35ug、0.36ug、0.37ug、0.38ug、0.39ug、0.40ug、0.41ug、0.42ug、0.43ug、0.44ug、0.45ug、0.46ug、0.47ug、0.48ug、0.49ug、0.50ug、0.51ug、0.52ug、0.53ug、0.54ug、0.55ug、0.56ug、0.57ug、0.58ug、0.59ug、0.60ug、0.61ug、0.62ug、0.63ug、0.64ug、0.65ug、0.66ug、0.67ug、0.68ug、0.69ug、0.70ug、0.71ug、0.72ug、0.73ug、0.74ug、0.75ug、0.76ug、0.77ug、0.78ug、0.79ug、0.80ug、0.81ug、0.82ug、0.83ug、0.84ug、0.85ug、0.86ug、0.87ug、0.88ug、0.89ug、0.90ug、0.91ug、0.92ug、0.93ug、0.94ug、0.95ug、0.96ug、0.97ug、0.98ug、0.99ug、1.00ug、1.01ug、1.02ug、1.03ug、1.04ug、1.05ug、1.06ug、1.07ug、1.08ug、1.09ug、1.1ug或这些数值之间的任何数值。使用此组合时,典型地,所述步骤(2)的Taq DNA Polymerase的使用活性单位量是1.25U~5U,优选为1.25U~2.5U, 进一步优选为1.25U。例如,可以具体选择1.25U、1.30U、1.35U、1.40U、1.45U、1.50U、1.55U、1.60U、1.65U、1.70U、1.75U、1.80U、1.85U、1.90U、1.95U、2.0U、2.05U、2.10U、2.15U、2.20U、2.25U、2.30U、2.35U、2.40U、2.45U、2.50U、2.55U、2.60U、2.65U、2.70U、2.75U、2.80U、2.85U、2.90U、2.95U、3.0U、3.05U、3.10U、3.15U、3.20U、3.25U、3.30U、3.35U、3.40U、3.45U、3.50U、3.55U、3.60U、3.65U、3.70U、3.75U、3.80U、3.85U、3.90U、3.95U、4.0U、4.05U、4.10U、4.15U、4.20U、4.25U、4.30U、4.35U、4.40U、4.45U、4.50U、4.55U、4.60U、4.65U、4.70U、4.75U、4.80U、4.85U、4.90U、4.95U、5.0U或这些数值之间的任何数值。使用此组合时,典型地,所述步骤(1)的反应条件可为:45℃-68℃,20分钟,优选反应温度为50℃-62℃,进一步优选为50℃或60℃。例如,可以具体选择45℃、46℃、47℃、48℃、49℃、50℃、51℃、52℃、53℃、54℃、55℃、56℃、57℃、58℃、59℃、60℃、61℃、62℃、63℃、64℃、65℃、66℃、67℃、68℃或这些数值之间的任何数值。In the first mode, the DNA polymerase is a single polymerase or the same type of polymerase Mixed enzymes of synthases, characterized in that the enzymes have 5'-3' polymerization activity and 5'-3' exo-cleavage activity but no 3'-5' exo-cleavage activity. Preferably, the DNA polymerase used in this first approach is Taq DNA Polymerase. Preferably, in the first mode, the reaction temperature in step 2) is fixed, and the temperature range is preferably 40-65°C, more preferably 50-60°C. For example, 40°C, 41°C, 42°C, 43°C, 44°C, 45°C, 46°C, 47°C, 48°C, 49°C, 50°C, 51°C, 52°C, 53°C, 54°C, 55°C, 56°C, 57°C, 58°C, 59°C, 60°C or any value between these values. Further preferably, a combination of the above-mentioned Vvn endonuclease and Taq DNA Polymerase is used to carry out the above step 2), so that the Vvn endonuclease randomly generates a single-stranded nick on the double-stranded DNA, and Taq DNA Polymerase uses this nick from The 5' end is translated to the 3' end to achieve random fragmentation of DNA and add A. When using this combination, typically, the amount of Vvn used in the step (2) is 0.11ug-1.1ug, preferably 0.33ug-1.1ug, more preferably 0.88ug. For example, 0.11ug, 0.12ug, 0.13ug, 0.14ug, 0.15ug, 0.16ug, 0.17ug, 0.18ug, 0.19ug, 0.20ug, 0.21ug, 0.22ug, 0.23ug, 0.24ug, 0.25ug, 0.26ug, 0.27ug, 0.28ug, 0.29ug, 0.30ug, 0.31ug, 0.32ug, 0.33ug, 0.34ug, 0.35ug, 0.36ug, 0.37ug, 0.38ug, 0.39ug, 0.40ug, 0.41ug, 0.42ug , 0.43ug, 0.44ug, 0.45ug, 0.46ug, 0.47ug, 0.48ug, 0.49ug, 0.50ug, 0.51ug, 0.52ug, 0.53ug, 0.54ug, 0.55ug, 0.56ug, 0.57ug, 0.58ug, 0.59 ug, 0.60ug, 0.61ug, 0.62ug, 0.63ug, 0.64ug, 0.65ug, 0.66ug, 0.67ug, 0.68ug, 0.69ug, 0.70ug, 0.71ug, 0.72ug, 0.73ug, 0.74ug, 0.75ug, 0.76ug, 0.77ug, 0.78ug, 0.79ug, 0.80ug, 0.81ug, 0.82ug, 0.83ug, 0.84ug, 0.85ug, 0.86ug, 0.87ug, 0.88ug, 0.89ug, 0.90ug, 0.91ug, 0.92ug , 0.93ug, 0.94ug, 0.95ug, 0.96ug, 0.97ug, 0.98ug, 0.99ug, 1.00ug, 1.01ug, 1.02ug, 1.03ug, 1.04ug, 1.05ug, 1.06ug, 1.07ug, 1.08ug, 1.09 ug, 1.1ug, or any value in between. When using this combination, typically, the usage activity unit amount of Taq DNA Polymerase in the step (2) is 1.25U~5U, preferably 1.25U~2.5U, More preferably 1.25U. For example, 1.25U, 1.30U, 1.35U, 1.40U, 1.45U, 1.50U, 1.55U, 1.60U, 1.65U, 1.70U, 1.75U, 1.80U, 1.85U, 1.90U, 1.95U, 2.0U, 2.05U, 2.10U, 2.15U, 2.20U, 2.25U, 2.30U, 2.35U, 2.40U, 2.45U, 2.50U, 2.55U, 2.60U, 2.65U, 2.70U, 2.75U, 2.80U , 2.85U, 2.90U, 2.95U, 3.0U, 3.05U, 3.10U, 3.15U, 3.20U, 3.25U, 3.30U, 3.35U, 3.40U, 3.45U, 3.50U, 3.55U, 3.60U, 3.65 U, 3.70U, 3.75U, 3.80U, 3.85U, 3.90U, 3.95U, 4.0U, 4.05U, 4.10U, 4.15U, 4.20U, 4.25U, 4.30U, 4.35U, 4.40U, 4.45U, 4.50U, 4.55U, 4.60U, 4.65U, 4.70U, 4.75U, 4.80U, 4.85U, 4.90U, 4.95U, 5.0U, or any value in between. When using this combination, typically, the reaction conditions of the step (1) can be: 45°C-68°C, 20 minutes, preferably the reaction temperature is 50°C-62°C, more preferably 50°C or 60°C. For example, 45°C, 46°C, 47°C, 48°C, 49°C, 50°C, 51°C, 52°C, 53°C, 54°C, 55°C, 56°C, 57°C, 58°C, 59°C, 60°C, 61°C, 62°C, 63°C, 64°C, 65°C, 66°C, 67°C, 68°C or any value in between.
在第二种方式中,所述DNA聚合酶是两种类型聚合酶的混合酶,其中一种类型的聚合酶是具有5′-3′聚合活性以及3′-5′和5′-3′核酸外切活性;另一种聚合酶是具有5′-3′聚合活性和5′-3′核酸外切活性但不具有3′-5′核酸外切活性的聚合酶。优选地,在该第二种方式中使用的DNA聚合酶是DNA Polymerase I和Taq DNA Polymerase的混合酶。优选地,在该第二种方式中,步骤2)的反应温度是可变的,先用较低温度反应,再用较高的反应温度反应,其中较低反应温度优选30-50℃,更优选32-37℃,例如可以为30℃、31℃、32℃、33℃、34℃、35℃、36℃、37℃、38℃、39℃、40℃、41℃、42℃、43℃、44℃、45℃、46℃、47℃、48℃、49℃、50℃或这些数值之间的任何数值;较高反应温度优选60-75℃,更优选68-72℃,例如可以为60℃、61℃、62℃、63℃、64℃、65℃、66℃、67℃、68℃、69℃、70℃、71℃、72℃、73℃、74℃、75℃ 或这些数值之间的任何数值。典型地,所述步骤2)的反应条件可为:37℃5min-20min;68℃10min,优选反应条件为37℃5min-10min;68℃10min,进一步优选为37℃10min;68℃10min。进一步地,使用上述Vvn核酸内切酶+DNA Polymerase I+Taq DNA Polymerase的组合来进行上述步骤2),所述Vvn随机在双链DNA上产生单链切口,DNA Polymerase I以此切口从5’端向3’端平移,实现DNA的随机片段化,Taq DNA Polymerase实现片段化DNA加A。使用此组合时,典型地,所述步骤(2)的Vvn的使用量是0.011ug-0.11ug,优选为0.033ug-0.11ug,进一步优选为0.088ug。例如,可以具体选择0.011ug、0.012ug、0.013ug、0.014ug、0.015ug、0.016ug、0.017ug、0.018ug、0.019ug、0.020ug、0.021ug、0.022ug、0.023ug、0.024ug、0.025ug、0.026ug、0.027ug、0.028ug、0.029ug、0.030ug、0.031ug、0.032ug、0.033ug、0.034ug、0.035ug、0.036ug、0.037ug、0.038ug、0.039ug、0.040ug、0.041ug、0.042ug、0.043ug、0.044ug、0.045ug、0.046ug、0.047ug、0.048ug、0.049ug、0.050ug、0.051ug、0.052ug、0.053ug、0.054ug、0.055ug、0.056ug、0.057ug、0.058ug、0.059ug、0.060ug、0.061ug、0.062ug、0.063ug、0.064ug、0.065ug、0.066ug、0.067ug、0.068ug、0.069ug、0.070ug、0.071ug、0.072ug、0.073ug、0.074ug、0.075ug、0.076ug、0.077ug、0.078ug、0.079ug、0.080ug、0.081ug、0.082ug、0.083ug、0.084ug、0.085ug、0.086ug、0.087ug、0.088ug、0.089ug、0.090ug、0.091ug、0.092ug、0.093ug、0.094ug、0.095ug、0.096ug、0.097ug、0.098ug、0.099ug、0.100ug、0.101ug、0.102ug、0.103ug、0.104ug、0.105ug、0.106ug、0.107ug、0.108ug、0.109ug、0.11ug或这些数值之间的任何数值。使用此组合时,典型地,所述步骤(2)的DNA Polymerase I的使用量是3.2U~10U,优选为3.2U~10U,进一步优选3.2U,例如,可以具体选择3.20U、3.25U、3.30U、3.35U、 3.40U、3.45U、3.50U、3.55U、3.60U、3.65U、3.70U、3.75U、3.80U、3.85U、3.90U、3.95U、4.0U、4.05U、4.10U、4.15U、4.20U、4.25U、4.30U、4.35U、4.40U、4.45U、4.50U、4.55U、4.60U、4.65U、4.70U、4.75U、4.80U、4.85U、4.90U、4.95U、5.0U、5.20U、5.25U、5.30U、5.35U、5.40U、5.45U、5.50U、5.55U、5.60U、5.65U、5.70U、5.75U、5.80U、5.85U、5.90U、5.95U、6.0U、6.05U、6.10U、6.15U、6.20U、6.25U、6.30U、6.35U、6.40U、6.45U、6.50U、6.55U、6.60U、6.65U、6.70U、6.75U、6.80U、6.85U、6.90U、6.95U、7.0U、7.05U、7.10U、7.15U、7.20U、7.25U、7.30U、7.35U、7.40U、7.45U、7.50U、7.55U、7.60U、7.65U、7.70U、7.75U、7.80U、7.85U、7.90U、7.95U、8.0U、8.05U、8.10U、8.15U、8.20U、8.25U、8.30U、8.35U、8.40U、8.45U、8.50U、8.55U、8.60U、8.65U、8.70U、8.75U、8.80U、8.85U、8.90U、8.95U、9.0U、9.05U、9.10U、9.15U、9.20U、9.25U、9.30U、9.35U、9.40U、9.45U、9.50U、9.55U、9.60U、9.65U、9.70U、9.75U、9.80U、9.85U、9.90U、9.95U、10.0U或这些数值之间的任何数值。使用此组合时,典型地,所述步骤(2)的Taq DNA Polymerase的使用活性单位量是1.25U~5U,优选为1.25U~2.5U,进一步优选为1.25U,例如,可以具体选择1.25U、1.30U、1.35U、1.40U、1.45U、1.50U、1.55U、1.60U、1.65U、1.70U、1.75U、1.80U、1.85U、1.90U、1.95U、2.0U、2.05U、2.10U、2.15U、2.20U、2.25U、2.30U、2.35U、2.40U、2.45U、2.50U、2.55U、2.60U、2.65U、2.70U、2.75U、2.80U、2.85U、2.90U、2.95U、3.0U、3.05U、3.10U、3.15U、3.20U、3.25U、3.30U、3.35U、3.40U、3.45U、3.50U、3.55U、3.60U、3.65U、3.70U、3.75U、3.80U、3.85U、3.90U、3.95U、4.0U、4.05U、4.10U、4.15U、4.20U、4.25U、4.30U、4.35U、4.40U、4.45U、4.50U、4.55U、4.60U、4.65U、4.70U、4.75U、4.80U、4.85U、4.90U、4.95U、5.0U或这些数值之间的任何数值。 In the second mode, the DNA polymerase is a mixture of two types of polymerases, one of which has 5'-3' polymerization activity and 3'-5' and 5'-3' Exonucleolytic activity; another polymerase is a polymerase that has 5'-3' polymerization activity and 5'-3' exonucleolytic activity but does not have 3'-5' exonucleolytic activity. Preferably, the DNA polymerase used in the second mode is a mixed enzyme of DNA Polymerase I and Taq DNA Polymerase. Preferably, in the second mode, the reaction temperature of step 2) is variable, first react at a lower temperature, and then react at a higher reaction temperature, wherein the lower reaction temperature is preferably 30-50°C, more preferably Preferably 32-37°C, such as 30°C, 31°C, 32°C, 33°C, 34°C, 35°C, 36°C, 37°C, 38°C, 39°C, 40°C, 41°C, 42°C, 43°C , 44°C, 45°C, 46°C, 47°C, 48°C, 49°C, 50°C or any value between these values; the higher reaction temperature is preferably 60-75°C, more preferably 68-72°C, for example can be 60°C, 61°C, 62°C, 63°C, 64°C, 65°C, 66°C, 67°C, 68°C, 69°C, 70°C, 71°C, 72°C, 73°C, 74°C, 75°C or any value between these values. Typically, the reaction conditions of step 2) can be: 37°C for 5min-20min; 68°C for 10min, preferably 37°C for 5min-10min; 68°C for 10min, more preferably 37°C for 10min; 68°C for 10min. Further, use the combination of the above-mentioned Vvn endonuclease+DNA Polymerase I+Taq DNA Polymerase to carry out the above step 2), the Vvn randomly generates a single-stranded nick on the double-stranded DNA, and DNA Polymerase I uses this nick from the 5' The end is translated to the 3' end to realize random fragmentation of DNA, and Taq DNA Polymerase realizes the addition of A to fragmented DNA. When using this combination, typically, the amount of Vvn used in the step (2) is 0.011ug-0.11ug, preferably 0.033ug-0.11ug, more preferably 0.088ug. For example, 0.011ug, 0.012ug, 0.013ug, 0.014ug, 0.015ug, 0.016ug, 0.017ug, 0.018ug, 0.019ug, 0.020ug, 0.021ug, 0.022ug, 0.023ug, 0.024ug, 0.025ug, 0.026ug, 0.027ug, 0.028ug, 0.029ug, 0.030ug, 0.031ug, 0.032ug, 0.033ug, 0.034ug, 0.035ug, 0.036ug, 0.037ug, 0.038ug, 0.039ug, 0.040ug, 0.041ug, 0.042ug , 0.043ug, 0.044ug, 0.045ug, 0.046ug, 0.047ug, 0.048ug, 0.049ug, 0.050ug, 0.051ug, 0.052ug, 0.053ug, 0.054ug, 0.055ug, 0.056ug, 0.057ug, 0.058ug, 0.059 ug, 0.060ug, 0.061ug, 0.062ug, 0.063ug, 0.064ug, 0.065ug, 0.066ug, 0.067ug, 0.068ug, 0.069ug, 0.070ug, 0.071ug, 0.072ug, 0.073ug, 0.074ug, 0.075ug, 0.076ug, 0.077ug, 0.078ug, 0.079ug, 0.080ug, 0.081ug, 0.082ug, 0.083ug, 0.084ug, 0.085ug, 0.086ug, 0.087ug, 0.088ug, 0.089ug, 0.090ug, 0.091ug, 0.092ug , 0.093ug, 0.094ug, 0.095ug, 0.096ug, 0.097ug, 0.098ug, 0.099ug, 0.100ug, 0.101ug, 0.102ug, 0.103ug, 0.104ug, 0.105ug, 0.106ug, 0.107ug, 0.108ug, 0.109 ug, 0.11ug, or any value in between. When using this combination, typically, the amount of DNA Polymerase I used in the step (2) is 3.2U to 10U, preferably 3.2U to 10U, more preferably 3.2U, for example, 3.20U, 3.25U, 3.25U, 3.30U, 3.35U, 3.40U, 3.45U, 3.50U, 3.55U, 3.60U, 3.65U, 3.70U, 3.75U, 3.80U, 3.85U, 3.90U, 3.95U, 4.0U, 4.05U, 4.10U, 4.15U, 4.20U , 4.25U, 4.30U, 4.35U, 4.40U, 4.45U, 4.50U, 4.55U, 4.60U, 4.65U, 4.70U, 4.75U, 4.80U, 4.85U, 4.90U, 4.95U, 5.0U, 5.20 U, 5.25U, 5.30U, 5.35U, 5.40U, 5.45U, 5.50U, 5.55U, 5.60U, 5.65U, 5.70U, 5.75U, 5.80U, 5.85U, 5.90U, 5.95U, 6.0U, 6.05U, 6.10U, 6.15U, 6.20U, 6.25U, 6.30U, 6.35U, 6.40U, 6.45U, 6.50U, 6.55U, 6.60U, 6.65U, 6.70U, 6.75U, 6.80U, 6.85U , 6.90U, 6.95U, 7.0U, 7.05U, 7.10U, 7.15U, 7.20U, 7.25U, 7.30U, 7.35U, 7.40U, 7.45U, 7.50U, 7.55U, 7.60U, 7.65U, 7.70 U, 7.75U, 7.80U, 7.85U, 7.90U, 7.95U, 8.0U, 8.05U, 8.10U, 8.15U, 8.20U, 8.25U, 8.30U, 8.35U, 8.40U, 8.45U, 8.50U, 8.55U, 8.60U, 8.65U, 8.70U, 8.75U, 8.80U, 8.85U, 8.90U, 8.95U, 9.0U, 9.05U, 9.10U, 9.15U, 9.20U, 9.25U, 9.30U, 9.35U , 9.40U, 9.45U, 9.50U, 9.55U, 9.60U, 9.65U, 9.70U, 9.75U, 9.80U, 9.85U, 9.90U, 9.95U, 10.0U, or any value in between. When using this combination, typically, the use activity unit amount of Taq DNA Polymerase in the step (2) is 1.25U~5U, preferably 1.25U~2.5U, more preferably 1.25U, for example, 1.25U can be specifically selected , 1.30U, 1.35U, 1.40U, 1.45U, 1.50U, 1.55U, 1.60U, 1.65U, 1.70U, 1.75U, 1.80U, 1.85U, 1.90U, 1.95U, 2.0U, 2.05U, 2.10 U, 2.15U, 2.20U, 2.25U, 2.30U, 2.35U, 2.40U, 2.45U, 2.50U, 2.55U, 2.60U, 2.65U, 2.70U, 2.75U, 2.80U, 2.85U, 2.90U, 2.95U, 3.0U, 3.05U, 3.10U, 3.15U, 3.20U, 3.25U, 3.30U, 3.35U, 3.40U, 3.45U, 3.50U, 3.55U, 3.60U, 3.65U, 3.70U, 3.75U , 3.80U, 3.85U, 3.90U, 3.95U, 4.0U, 4.05U, 4.10U, 4.15U, 4.20U, 4.25U, 4.30U, 4.35U, 4.40U, 4.45U, 4.50U, 4.55U, 4.60 U, 4.65U, 4.70U, 4.75U, 4.80U, 4.85U, 4.90U, 4.95U, 5.0U, or any value in between.
关于本发明的第一示例实施方案的方法中的步骤2)和3),其可以在单一反应管中完成,中间不需要DNA纯化步骤。Regarding steps 2) and 3) in the method of the first exemplary embodiment of the present invention, it can be done in a single reaction tube without the need for a DNA purification step in between.
关于本发明的第一示例实施方案的方法,其可以不包含PCR扩增步骤。Regarding the method of the first exemplary embodiment of the present invention, it may not comprise a PCR amplification step.
关于本发明的第一示例实施方案的方法,其中所述文库用于检测染色体拷贝数变异。Regarding the method of the first exemplary embodiment of the present invention, wherein said library is used to detect chromosomal copy number variation.
用于构建高通量测序文库的试剂盒Kits for Construction of High-Throughput Sequencing Libraries
为了至少部分地解决上述问题以及其他潜在问题中的一个或者多个,本发明的第二示例实施方案提出用于构建高通量测序文库的试剂盒,包括:In order to at least partially address one or more of the above-mentioned problems and other potential problems, a second exemplary embodiment of the present invention proposes a kit for constructing a high-throughput sequencing library, comprising:
1)随机打切口并进行切口平移和末端加A的试剂;1) Make random cuts and perform cut translation and add A reagent at the end;
2)将所述加A后的DNA片段与测序接头连接的试剂;和2) a reagent for ligating the A-added DNA fragment with a sequencing adapter; and
3)用于纯化所述连接产物的试剂。3) Reagents for purifying the ligated product.
关于所述随机打切口并进行切口平移和末端加A的试剂,并无特别限制,可以为本领域中常规使用的那些,但优选地,其包括核酸内切酶,DNA聚合酶和dNTP。There are no particular limitations on the reagents for randomly nicking, nick translation and end-adding, and may be those routinely used in the art, but preferably, they include endonucleases, DNA polymerases and dNTPs.
关于核酸内切酶,并无特别限制,可以为本领域中常规使用的那些。但是,优选地,所述核酸内切酶是源自弧菌的核酸内切酶,更优选源自嗜盐弧菌(Vibrio vulnificus)(Vvn)的Vvn核酸内切酶。进一步地,所述核酸内切酶还可以是Vvn核酸内切酶的野生型或其突变体。As for the endonuclease, there is no particular limitation, and those conventionally used in the art may be used. However, preferably, the endonuclease is a Vibrio-derived endonuclease, more preferably a Vvn endonuclease derived from halophilic Vibrio (Vibrio vulnificus) (Vvn). Further, the endonuclease can also be a wild-type Vvn endonuclease or a mutant thereof.
关于DNA聚合酶,并无特别限制,可以为本领域中常规使用的那些。但是,优选地,所述DNA聚合酶可以采用下述两种方式之一使用。As for the DNA polymerase, there is no particular limitation, and those conventionally used in the art may be used. However, preferably, the DNA polymerase can be used in one of the following two ways.
在第一种方式中,所述DNA聚合酶是聚合酶单酶或同种类型聚合酶的混合酶,其特点是所述酶具有5′-3′聚合活性和5′-3′外切活性但不具有3′-5′外切活性。优选地,在该第一种方式中使用的DNA聚合酶是Taq DNA Polymerase。 In the first mode, the DNA polymerase is a polymerase single enzyme or a mixed enzyme of the same type of polymerase, which is characterized in that the enzyme has 5'-3' polymerization activity and 5'-3' excision activity But it does not have 3'-5'exo-cutting activity. Preferably, the DNA polymerase used in this first approach is Taq DNA Polymerase.
在第二种方式中,所述DNA聚合酶是两种类型聚合酶的混合酶,其中一种类型的聚合酶是具有5′-3′聚合活性以及3′-5′和5′-3′核酸外切活性;另一种聚合酶是具有5′-3′聚合活性和5′-3′核酸外切活性但不具有3′-5′核酸外切活性的聚合酶。优选地,在该第二种方式中使用的DNA聚合酶是DNA Polymerase I和Taq DNA Polymerase的混合酶。In the second mode, the DNA polymerase is a mixture of two types of polymerases, one of which has 5'-3' polymerization activity and 3'-5' and 5'-3' Exonucleolytic activity; another polymerase is a polymerase that has 5'-3' polymerization activity and 5'-3' exonucleolytic activity but does not have 3'-5' exonucleolytic activity. Preferably, the DNA polymerase used in the second mode is a mixed enzyme of DNA Polymerase I and Taq DNA Polymerase.
关于将所述加A后的DNA片段与测序接头连接的试剂,并无特别限制,可以为本领域中常规使用的那些。但是,优选地,将所述加A后的DNA片段与测序接头连接的试剂包括连接酶。The reagents for ligating the A-added DNA fragments to the sequencing adapters are not particularly limited, and may be those routinely used in the art. However, preferably, the reagent for ligating the A-added DNA fragments to the sequencing adapters includes ligase.
关于连接酶,并无特别限制,可以为本领域中常规使用的那些。但是,优选地,所述连接酶是T4 DNA连接酶或者T7 DNA连接酶。As for the ligase, there is no particular limitation, and those conventionally used in the art may be used. However, preferably, the ligase is T4 DNA ligase or T7 DNA ligase.
关于用于纯化所述连接产物的试剂,并无特别限制,可以为本领域中常规使用的那些。但是,优选地,所述用于纯化所述连接产物的试剂选自纯化柱、Qiagen柱、纯化磁珠或者Beckman Ampure XP beads。There are no particular limitations on the reagents used to purify the ligation product, and may be those routinely used in the art. However, preferably, the reagents for purifying the ligated product are selected from purification columns, Qiagen columns, purification magnetic beads or Beckman Ampure XP beads.
优选实施例preferred embodiment
下面结合说明书附图,进一步对本发明的优选实施例进行详细描述,以下的描述为示例性的,并非对本发明的限制,任何的其他类似情形也都落入本发明的保护范围之中。The preferred embodiments of the present invention will be further described in detail below in conjunction with the accompanying drawings. The following descriptions are exemplary and not limiting to the present invention. Any other similar situations also fall within the protection scope of the present invention.
实施例1:确定VVn核酸内切酶的投入量。Embodiment 1: Determining the input amount of VVn endonuclease.
(1)将VVn按10-1/10-2/10-3/10-4分别稀释备用。(1) Dilute VVn by 10 -1 /10 -2 /10 -3 /10 -4 respectively for use.
(2)取100ng细胞系基因组DNA作为起始样本,按照表1在反应体系中依次加入43uL ddH2O,5uL 10×ds HL Reaction buffer,1uL DNA,1uL VVn至50uL。其中VVn包括不加入(阴性对照)、原液(100)、10-1、10-2、10-3、10-4 6种梯度。(2) Take 100ng of cell line genomic DNA as the initial sample, add 43uL ddH 2 O, 5uL 10×ds HL Reaction buffer, 1uL DNA, 1uL VVn to 50uL in sequence according to Table 1. Among them, VVn includes no addition (negative control), stock solution (10 0 ), 10 -1 , 10 -2 , 10 -3 , 10 -4 6 gradients.
(3)PCR仪反应程序设定为37℃20min;4℃forever。 (3) The reaction program of the PCR instrument was set at 37°C for 20 minutes; 4°C forever.
(4)反应完成后加入loading buffer,使用1.2%琼脂糖凝胶电泳检测打断片段的大小,电泳仪设定电压为120V,时间40min。图3展示出了上述电泳结果,图3上方给出了不同泳道中VVn的投入量,根据图3显示的结果可以知道,不同VVn的投入量对DNA的打断效果不同,当VVn稀释成10-1时,DNA的打断大小为100-200bp为较优选择。(4) Add loading buffer after the reaction is completed, and use 1.2% agarose gel electrophoresis to detect the size of the interrupted fragments. The electrophoresis instrument is set at a voltage of 120V for 40 minutes. Figure 3 shows the above electrophoresis results, and the input amount of VVn in different swimming lanes is given at the top of Figure 3. According to the results shown in Figure 3, it can be known that different input amounts of VVn have different effects on DNA interruption. When VVn is diluted to 10 When -1 , the DNA fragmentation size of 100-200bp is a better choice.
表1:
Table 1:
实施例2:确定Taq DNA Polymerase的投入量。Embodiment 2: Determine the input amount of Taq DNA Polymerase.
(1)为了确定Taq DNA Polymerase的投入量,分别设置反应体系中加入0.25、0.5、1.0、2.0uL不同的Taq DNA Polymerase。按表2依次加入ddH2O,5uL 10x PCR Reaction Buffer,1.0uL10mM dNTPs,1.0uL DNA,1.0uL VVn(稀释10倍),0.25/0.5/1/2.0uL Taq DNA Polymerase至50uL。(1) In order to determine the input amount of Taq DNA Polymerase, add 0.25, 0.5, 1.0, 2.0uL of different Taq DNA Polymerase into the reaction system respectively. According to Table 2, add ddH 2 O, 5uL 10x PCR Reaction Buffer, 1.0uL 10mM dNTPs, 1.0uL DNA, 1.0uL VVn (diluted 10 times), 0.25/0.5/1/2.0uL Taq DNA Polymerase to 50uL.
(2)PCR仪反应程序设定为37℃20min;68℃20min;4℃forever。(2) The reaction program of the PCR instrument was set as 37°C for 20 minutes; 68°C for 20 minutes; 4°C forever.
(3)将反应产物按照表3依次加入14.0uL连接缓冲液、5.0uL连接酶、4.0uL Adapter进行二代建库,获得连接产物。(3) Add 14.0uL ligation buffer, 5.0uL ligase, and 4.0uL Adapter to the reaction product in sequence according to Table 3 for second-generation library construction to obtain the ligation product.
(4)1x XP磁珠纯化去除未连接的片段以及多余接头,获得测序文库。(4) 1x XP magnetic bead purification to remove unligated fragments and redundant adapters to obtain a sequencing library.
(5)qPCR扩增确定文库的浓度。同时将qPCR产物加入loading buffer,使用1.2%琼脂糖凝胶电泳检测文库的大小,电泳仪设定电 压为120V,时间30min。图4展示出了上述电泳结果,图4上方给出了不同泳道中Taq DNA Polymerase的投入量,根据图4显示的结果可以知道,Taq DNA Polymerase的投入量是0.25uL(即1.25U)和0.5uL(即2.5U)时,文库的大小是300bp,弥散较小;当Taq DNA Polymerase的投入量是1.0uL和2.0uL时,文库弥散严重,且有大片段未被打断。(5) qPCR amplification to determine the concentration of the library. At the same time, add the qPCR product to the loading buffer, use 1.2% agarose gel electrophoresis to detect the size of the library, and set the electrophoresis The voltage is 120V, and the time is 30min. Figure 4 shows the above electrophoresis results, and the input amount of Taq DNA Polymerase in different swimming lanes is given at the top of Figure 4. According to the results shown in Figure 4, it can be known that the input amount of Taq DNA Polymerase is 0.25uL (ie 1.25U) and 0.5 When uL (ie 2.5U), the size of the library is 300bp, and the scatter is small; when the input amount of Taq DNA Polymerase is 1.0uL and 2.0uL, the library scatter is serious, and there are large fragments that are not interrupted.
表2:
Table 2:
表3:
table 3:
实施例3:确定VVn核酸内切酶和Taq DNA Polymerase的反应温度。Embodiment 3: Determine the reaction temperature of VVn endonuclease and Taq DNA Polymerase.
(1)按照表4依次加入反应试剂,其中VVn稀释10倍,Taq DNA Polymerase的投入量是0.25uL。(1) Add the reaction reagents sequentially according to Table 4, wherein VVn is diluted 10 times, and the input amount of Taq DNA Polymerase is 0.25uL.
(2)PCR仪反应程序设定为45℃ˉ68℃20min;4℃forever共9个温度梯度。(2) The reaction program of the PCR instrument was set at 45°C ˉ68°C for 20 minutes; 4°C forever with a total of 9 temperature gradients.
(3)将片段化产物按表3依次加入连接试剂进行二代建库,获得连接产物并纯化,qPCR扩增确定文库的浓度。(3) The fragmented products were sequentially added to the ligation reagents according to Table 3 for second-generation library construction, the ligated products were obtained and purified, and the concentration of the library was determined by qPCR amplification.
(4)上机测序:使用NextSeq CN500(国械注准20153400460)测序仪,根据制造商的说明进行上机测序。(4) On-machine sequencing: use the NextSeq CN500 (National Machinery Note 20153400460) sequencer to perform on-machine sequencing according to the manufacturer's instructions.
(5)分析测序数据:将测序数据与人类基因组参考序列进行比对,分析结果如表5所示:结果显示了各个反应温度下文库的浓度/uniq mapped reads/uniq mapped ratio/uniq GC ratio等信息,从各项数据结果可以知道,反应条件可为45℃~68℃,优选反应温度为50℃~62℃。(5) Analysis of sequencing data: compare the sequencing data with the reference sequence of the human genome, and the analysis results are shown in Table 5: the results show the concentration of the library at each reaction temperature/uniq mapped reads/uniq mapped ratio/uniq GC ratio, etc. Information, from the results of various data, it can be known that the reaction conditions can be 45°C to 68°C, and the preferred reaction temperature is 50°C to 62°C.
表4:
Table 4:
表5:
table 5:
实施例4:DNA起始含量对测序文库浓度的影响。 Example 4: Effect of DNA starting content on sequencing library concentration.
根据上述实施例确定的实验条件(VVn稀释10倍投入8uL,Taq DNA Polymerase投入0.25uL,反应温度60℃)构建文库,用起始含量不同的DNA样本制备测序文库,根据文库的浓度和体积计算所得文库的总量,结果如下表6所示。从表中可以看出,当DNA起始含量为3.5ngˉ1000ng时,所得文库的总量均大于0.2fmol,均可以满足测序需求。因此,用于制备文库的起始DNA含量范围为3.5ˉ1000ng,但不限于本范围。According to the experimental conditions determined in the above examples (VVn diluted 10 times into 8uL, Taq DNA Polymerase into 0.25uL, reaction temperature 60 ℃) to construct the library, use DNA samples with different initial content to prepare the sequencing library, calculate according to the concentration and volume of the library The total amount of the library obtained is shown in Table 6 below. It can be seen from the table that when the initial DNA content is 3.5ngˉ1000ng, the total amount of the obtained library is greater than 0.2fmol, which can meet the sequencing requirements. Therefore, the starting DNA content range for preparing the library is 3.5-1000ng, but not limited to this range.
表6:
Table 6:
实施例5:不同非整倍体样本的检测验证。Example 5: Detection verification of different aneuploid samples.
根据上述实施例确定的实验条件(VVn稀释10倍投入8uL,Taq DNA Polymerase投入0.25uL,反应温度60℃),采用不同非整倍体DNA样本构建文库,用于染色体拷贝数变异的检测。将测序结果与人类基因组参考序列进行比对,不同非整倍体DNA样本用该方法检测的结果如下表7和图5a-5k所示,染色体拷贝数变异均能正确检出。 According to the experimental conditions determined in the above examples (10-fold dilution of VVn into 8uL, Taq DNA Polymerase into 0.25uL, reaction temperature of 60°C), different aneuploid DNA samples were used to construct libraries for the detection of chromosome copy number variation. The sequencing results were compared with the reference sequence of the human genome. The results of different aneuploid DNA samples detected by this method are shown in Table 7 and Figures 5a-5k below. Chromosome copy number variations can be detected correctly.
表7:
Table 7:
实施例6:VVn和两种类型聚合酶的混合酶实现DNA的随机片段化。Example 6: A mixture of VVn and two types of polymerases achieves random fragmentation of DNA.
(1)按照表8依次加入反应试剂,其中VVn设置梯度分别加入稀释10倍(1uL)/稀释100倍(3/5/8uL),DNA Polymerase I的投入量是0.32uL,Taq DNA Polymerase的投入量是0.25uL。(1) Add reaction reagents in sequence according to Table 8, where VVn sets the gradient by adding 10 times of dilution (1uL)/100 times of dilution (3/5/8uL), the input amount of DNA Polymerase I is 0.32uL, and the input of Taq DNA Polymerase The volume is 0.25 uL.
(2)PCR仪反应程序设定为37℃10min(5min);68℃10min;4℃forever共2个温度梯度。(2) The reaction program of the PCR instrument was set as 37°C for 10 minutes (5 minutes); 68°C for 10 minutes; 4°C forever, a total of 2 temperature gradients.
(3)将片段化产物按表3依次加入连接试剂进行二代建库,获得连接产物并纯化,qPCR扩增确定文库的浓度。(3) The fragmented products were sequentially added to the ligation reagents according to Table 3 for second-generation library construction, the ligated products were obtained and purified, and the concentration of the library was determined by qPCR amplification.
(4)上机测序:使用NextSeq CN500(国械注准20153400460)测序仪,根据制造商的说明进行上机测序。(4) On-machine sequencing: use the NextSeq CN500 (National Machinery Note 20153400460) sequencer to perform on-machine sequencing according to the manufacturer's instructions.
(5)分析测序数据:将测序数据与人类基因组参考序列进行比对,分析结果如表9所示:结果显示了各个反应条件下文库的浓度/uniq mapped reads/uniq mapped ratio/uniq GC ratio等信息,从各项数据结果可以知道,VVn稀释100倍加入5.0uL或8uL均取得明显的有益技术效果,其中反应条件为37℃10min;68℃10min;4℃ forever是优选反应温度。(5) Analysis of sequencing data: compare the sequencing data with the reference sequence of the human genome, and the analysis results are shown in Table 9: the results show the concentration of the library under each reaction condition/uniq mapped reads/uniq mapped ratio/uniq GC ratio, etc. Information, from the results of various data, it can be known that VVn diluted 100 times and added to 5.0uL or 8uL has obvious beneficial technical effects. The reaction conditions are 37°C for 10min; 68°C for 10min; 4°C forever is the preferred reaction temperature.
表8:
Table 8:
表9:
Table 9:
实施例7:VVn和两种类型聚合酶的混合酶实现DNA的随机片段化,进行染色体微缺失综合征的检测。Example 7: The mixed enzyme of VVn and two types of polymerases realizes the random fragmentation of DNA and detects chromosome microdeletion syndrome.
根据实施例6确定的实验条件,采用三种染色体微缺失综合征DNA样本构建文库,用于染色体微缺失DNA拷贝数变异的检测。将测序结果与人类基因组参考序列进行比对,不同DNA样本用该方法检测的结果如下表10和图6所示,对应区域的DNA拷贝数异常情况均能正确检出。According to the experimental conditions determined in Example 6, three DNA samples of chromosome microdeletion syndrome were used to construct a library for detection of DNA copy number variation of chromosome microdeletion. The sequencing results were compared with the reference sequence of the human genome. The detection results of different DNA samples using this method are shown in Table 10 and Figure 6 below. Abnormalities in the DNA copy number in the corresponding regions can be detected correctly.
表10:
Table 10:
实施例8:VVn核酸内切酶+Taq DNA Polymerase实现对RNA/DNA杂合双链的随机片段化。Example 8: VVn endonuclease+Taq DNA Polymerase realizes random fragmentation of RNA/DNA hybrid double strands.
(1)取总RNA用oligo(dT)引物或随机引物合成RNA/DNA杂合双链。(1) Take total RNA and use oligo(dT) primers or random primers to synthesize RNA/DNA hybrid double strands.
(2)根据上述实施例3确定的实验条件(VVn稀释10倍投入8uL,Taq DNA Polymerase投入0.25uL,反应温度60℃)构建文库。(2) The library was constructed according to the experimental conditions determined in the above-mentioned Example 3 (VVn was diluted 10 times into 8uL, Taq DNA Polymerase into 0.25uL, and the reaction temperature was 60°C).
(3)qPCR扩增确定文库的浓度,浓度结果如表11所示,从表中可以看出,用该发明方法对RNA/DNA杂合双链随机片段化建库后,所得文库的总量大于0.2fmol,均可以满足测序需求,表明该方法可以实现对RNA/DNA杂合双链的随机片段化。(3) qPCR amplification determines the concentration of the library, and the concentration results are as shown in Table 11. As can be seen from the table, after the random fragmentation of RNA/DNA hybrid double strands is used to build a library by the inventive method, the total amount of the library obtained is Greater than 0.2 fmol, all can meet the sequencing requirements, indicating that this method can achieve random fragmentation of RNA/DNA hybrid double strands.
表11:
Table 11:
综上,本发明的用于构建高通量测序文库的方法,提供了一种新型有效的片段化技术和快速的建库方法,其可以更高效地构建检测染色体拷贝数变异的测序文库,取得了明显的有益技术效果。In summary, the method for constructing a high-throughput sequencing library of the present invention provides a new and effective fragmentation technology and a rapid library construction method, which can more efficiently construct a sequencing library for detecting chromosome copy number variation, and obtain Obvious beneficial technical effects have been achieved.
前述的示例仅是说明性的,用于解释本发明的特征的一些特征。 所附的权利要求旨在要求可以设想的尽可能广的范围,且本文所呈现的实施例仅是根据所有可能的实施例的组合的选择的实施方式的说明。因此,申请人的用意是所附的权利要求并不被说明本申请的特征的示例的选择限制。如在权利要求中使用的,术语“包括”和其语意上的变体在逻辑上也包括不同和变化的用语,例如但不限于“基本组成为”或“组成为”。当需要时,提供了一些数值范围,而这些范围也包括了在其之间的子范围。这些范围中的变化也对于本领域技术人员也是自明的,且不应被认为被捐献给公众,而这些变化也应在可能的情况下被解释为被所附的权利要求覆盖。而且在科技上的进步将形成由于语言表达的不准确的原因而未被目前考虑的可能的等同物或子替换,且这些变化也应在可能的情况下被解释为被所附的权利要求覆盖。The foregoing examples are illustrative only, serving to explain some of the characteristic features of the invention. The appended claims are intended to claim the broadest scope conceivable and the embodiments presented herein are merely illustrations of selected implementations according to all possible combinations of embodiments. Accordingly, it is the Applicant's intent that the appended claims not be limited by the selection of examples which characterize the application. As used in the claims, the term "comprises" and its semantic variants also logically include different and varied terms, such as but not limited to "consists essentially of" or "consists of". Where necessary, numerical ranges are provided and these ranges include subranges therebetween. Variations within these ranges will also be self-evident to those skilled in the art and should not be considered as a contribution to the public, but should also be construed, where possible, to be covered by the appended claims. Moreover, advances in science and technology will create possible equivalents or sub-replacements not presently considered due to inaccuracies of language, and these changes should also be construed to be covered by the appended claims where possible .
参考文献references
1.Nord A,Salipante SJ,Pritchard C.Chapter 11–Copy Number Variant Detection Using Next-Generation Sequencing.Clinical Genomics,2015,8:165-187.1.Nord A, Salipante SJ, Pritchard C.Chapter 11–Copy Number Variant Detection Using Next-Generation Sequencing.Clinical Genomics,2015,8:165-187.
2.Trask BJ.Fluoresence in situ hybridization:application in cytogenetics 15and gene mapping.Trends Gnent.1991,7:149-154.2. Trask BJ. Fluoresence in situ hybridization: application in cytogenetics 15 and gene mapping. Trends Gnent. 1991, 7:149-154.
3.Manning M,and Hudgins L.Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities.Genet.Med.2010,12(11):742-745.3. Manning M, and Hudgins L. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet. Med. 2010,12(11):742-745.
4.Xuan J,Yu Y,Qing T,Guo L,Shi L.Next-generation sequencing in 25 the clinic:promises and challenges.Cancer Lett.2013,340(2):284-295. 4. Xuan J, Yu Y, Qing T, Guo L, Shi L. Next-generation sequencing in 25 the clinic: promises and challenges. Cancer Lett. 2013, 340(2): 284-295.

Claims (29)

  1. 用于构建高通量测序文库的方法,包括以下步骤:A method for constructing a high-throughput sequencing library, comprising the following steps:
    1)提供基因组DNA或RNA/DNA杂合双链样品;1) Provide genomic DNA or RNA/DNA hybrid double-stranded samples;
    2)向上述样品中加入核酸内切酶和DNA聚合酶,利用切口平移原理将DNA双链或RNA/DNA杂合双链随机打断得到DNA片段并在片段末端加A,以得到加A后的DNA片段;2) Add endonuclease and DNA polymerase to the above sample, use the principle of nick translation to randomly interrupt the DNA double strand or RNA/DNA hybrid double strand to obtain DNA fragments, and add A to the end of the fragment to obtain the A-added DNA fragments;
    3)将所述加A后的DNA片段与测序接头连接获得连接产物;3) Ligate the A-added DNA fragments with a sequencing adapter to obtain a ligation product;
    4)纯化所述连接产物,获得测序文库。4) purifying the ligation product to obtain a sequencing library.
  2. 权利要求1所述的方法,其中所述核酸内切酶是源自弧菌的核酸内切酶。The method of claim 1, wherein the endonuclease is an endonuclease derived from Vibrio.
  3. 权利要求1所述的方法,其中所述核酸内切酶是源自嗜盐弧菌的Vvn核酸内切酶。The method of claim 1, wherein the endonuclease is a Vvn endonuclease derived from Vibrio halophilus.
  4. 权利要求1所述的方法,其中所述DNA聚合酶是聚合酶单酶或同种类型聚合酶的混合酶,其特点是所述酶具有5′-3′聚合活性和5′-3′外切活性但不具有3′-5′外切活性。The method of claim 1, wherein the DNA polymerase is a polymerase single enzyme or a mixed enzyme of the same type of polymerase, which is characterized in that the enzyme has 5'-3' polymerization activity and 5'-3' outer cleavage activity but no 3'-5' exocleavage activity.
  5. 权利要求4所述的方法,其中所述DNA聚合酶是Taq DNA Polymerase。The method of claim 4, wherein the DNA polymerase is Taq DNA Polymerase.
  6. 权利要求4所述的方法,其中步骤2)的反应温度固定。The method of claim 4, wherein the reaction temperature of step 2) is fixed.
  7. 权利要求4所述的方法,其中步骤2)的反应温度为40-65℃。The method according to claim 4, wherein the reaction temperature of step 2) is 40-65°C.
  8. 权利要求4所述的方法,其中步骤2)的反应温度为50-60℃。The method of claim 4, wherein the reaction temperature of step 2) is 50-60°C.
  9. 权利要求1所述的方法,其中所述DNA聚合酶是两种类型聚合酶的混合酶,其中一种类型的聚合酶是具有5′-3′聚合活性以及3′-5′和5′-3′核酸外切活性;另一种聚合酶是具有5′-3′聚合活性和5′-3′核酸外切活性但不具有3′-5′核酸外切活性的聚合酶。The method of claim 1, wherein the DNA polymerase is a mixed enzyme of two types of polymerases, wherein one type of polymerase has 5'-3' polymerization activity and 3'-5' and 5'- 3' exonucleolytic activity; another polymerase is a polymerase that has 5'-3' polymerization activity and 5'-3' exonucleolytic activity but does not have 3'-5' exonucleolytic activity.
  10. 权利要求9所述的方法,其中所述DNA聚合酶是DNA Polymerase I和Taq DNA Polymerase的混合酶。The method of claim 9, wherein the DNA polymerase is a mixed enzyme of DNA Polymerase I and Taq DNA Polymerase.
  11. 权利要求9的所述的方法,其中步骤2)的反应温度是可变的,先用较低温度反应,再用较高的反应温度反应。 The described method of claim 9, wherein the reaction temperature of step 2) is variable, first react with lower temperature, and then react with higher reaction temperature.
  12. 权利要求11所述的方法,其中所述较低反应温度为30-50℃。The method of claim 11, wherein the lower reaction temperature is 30-50°C.
  13. 权利要求11所述的方法,其中所述较低反应温度为32-37℃。The method of claim 11, wherein the lower reaction temperature is 32-37°C.
  14. 权利要求11所述的方法,其中所述较高反应温度为60-75℃。The method of claim 11, wherein the higher reaction temperature is 60-75°C.
  15. 权利要求11所述的方法,其中所述较高反应温度为68-72℃。The method of claim 11, wherein the higher reaction temperature is 68-72°C.
  16. 权利要求1所述的方法,其中步骤2)和3)在单一反应管中完成,中间不需要DNA纯化步骤。The method according to claim 1, wherein steps 2) and 3) are completed in a single reaction tube without a DNA purification step in the middle.
  17. 权利要求1所述的方法,其不包含PCR扩增步骤。The method of claim 1, which does not comprise a PCR amplification step.
  18. 根据权利要求1-17任一项的方法,其中所述文库用于检测染色体拷贝数变异。The method according to any one of claims 1-17, wherein said library is used to detect chromosomal copy number variation.
  19. 用于构建高通量测序文库的试剂盒,包括:Kits for constructing high-throughput sequencing libraries, including:
    1)随机打切口并进行切口平移和末端加A的试剂;1) Make random cuts and perform cut translation and add A reagent at the end;
    2)将所述加A后的DNA片段与测序接头连接的试剂;和2) a reagent for ligating the A-added DNA fragment with a sequencing adapter; and
    3)用于纯化所述连接产物的试剂。3) Reagents for purifying the ligated product.
  20. 权利要求19的试剂盒,其中所述随机打切口并进行切口平移和末端加A的试剂包括核酸内切酶,DNA聚合酶和dNTP。The kit according to claim 19, wherein the reagents for randomly making nicks and performing nick translation and adding A to the end include endonuclease, DNA polymerase and dNTP.
  21. 权利要求20所述的试剂盒,其中所述核酸内切酶是源自弧菌的核酸内切酶。The kit of claim 20, wherein the endonuclease is an endonuclease derived from Vibrio.
  22. 权利要求20所述的试剂盒,其中所述核酸内切酶是源自嗜盐弧菌的Vvn核酸内切酶。The kit of claim 20, wherein the endonuclease is a Vvn endonuclease derived from Vibrio halophilus.
  23. 权利要求20所述的试剂盒,其中所述DNA聚合酶是聚合酶单酶或同种类型聚合酶的混合酶,其特点是所述酶具有5′-3′聚合活性和5′-3′外切活性但不具有3′-5′外切活性。The kit according to claim 20, wherein the DNA polymerase is a polymerase single enzyme or a mixed enzyme of the same type of polymerase, which is characterized in that the enzyme has 5'-3' polymerization activity and 5'-3' Exo-active but not 3'-5'-exo-active.
  24. 权利要求23所述的试剂盒,其中所述DNA聚合酶是Taq DNA Polymerase。The kit of claim 23, wherein the DNA polymerase is Taq DNA Polymerase.
  25. 权利要求20所述的试剂盒,其中所述DNA聚合酶是两种类 型聚合酶的混合酶,其中一种类型的聚合酶是具有5′-3′聚合活性以及3′-5′和5′-3′核酸外切活性;另一种聚合酶是具有5′-3′聚合活性和5′-3′核酸外切活性但不具有3′-5′核酸外切活性的聚合酶。The described test kit of claim 20, wherein said DNA polymerase is two kinds A mixed enzyme of type polymerase, wherein one type of polymerase has 5'-3' polymerization activity and 3'-5' and 5'-3' exonuclease activity; the other polymerase has 5'- A polymerase with 3' polymerization activity and 5'-3' exonucleolytic activity but no 3'-5' exonucleolytic activity.
  26. 权利要求25所述的试剂盒,其中所述DNA聚合酶是DNA Polymerase I和Taq DNA Polymerase的混合酶。The test kit according to claim 25, wherein said DNA polymerase is a mixed enzyme of DNA Polymerase I and Taq DNA Polymerase.
  27. 权利要求19所述试剂盒,其中将所述加A后的DNA片段与测序接头连接的试剂包括连接酶。The kit according to claim 19, wherein the reagents for ligating the A-added DNA fragments with sequencing adapters include ligase.
  28. 权利要求27所述的试剂盒,其中所述连接酶是T4 DNA连接酶或者T7 DNA连接酶。The test kit of claim 27, wherein the ligase is T4 DNA ligase or T7 DNA ligase.
  29. 权利要求19所述的试剂盒,其中所述用于纯化所述连接产物的试剂选自纯化柱、Qiagen柱、纯化磁珠或者Beckman Ampure XP beads。 The kit of claim 19, wherein the reagents for purifying the ligated product are selected from purification columns, Qiagen columns, purification magnetic beads or Beckman Ampure XP beads.
PCT/CN2023/076541 2022-02-17 2023-02-16 Method and kit for constructing sequencing library for detecting chromosome copy number variation WO2023155847A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202210143977.3A CN114197061A (en) 2022-02-17 2022-02-17 Method and kit for constructing sequencing library for detecting chromosome copy number variation
CN202210143977.3 2022-02-17

Publications (1)

Publication Number Publication Date
WO2023155847A1 true WO2023155847A1 (en) 2023-08-24

Family

ID=80645460

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2023/076541 WO2023155847A1 (en) 2022-02-17 2023-02-16 Method and kit for constructing sequencing library for detecting chromosome copy number variation

Country Status (2)

Country Link
CN (1) CN114197061A (en)
WO (1) WO2023155847A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114197061A (en) * 2022-02-17 2022-03-18 北京贝瑞和康生物技术有限公司 Method and kit for constructing sequencing library for detecting chromosome copy number variation

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103827318A (en) * 2011-05-27 2014-05-28 生命技术公司 Methods for manipulating biomolecules
CN107217308A (en) * 2017-06-21 2017-09-29 北京贝瑞和康生物技术股份有限公司 A kind of sequencing library construction method and kit for being used to detect chromosome copies number variation
US20190153435A1 (en) * 2017-11-22 2019-05-23 New England Biolabs, Inc. Method for Fragmenting DNA by Nick Translation
WO2021027810A1 (en) * 2019-08-12 2021-02-18 深圳市真迈生物科技有限公司 Nucleic acid sample processing method, sequencing method and kit
CN113337487A (en) * 2021-02-09 2021-09-03 南京诺唯赞生物科技股份有限公司 Enzyme composition for nucleic acid fragmentation and application thereof
WO2022001149A1 (en) * 2020-06-28 2022-01-06 江苏康科斯医疗科技有限公司 Enzyme reaction solution for constructing sequencing library and use thereof
CN114197061A (en) * 2022-02-17 2022-03-18 北京贝瑞和康生物技术有限公司 Method and kit for constructing sequencing library for detecting chromosome copy number variation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ337900A (en) * 1997-03-18 2001-05-25 Novo Nordisk As DNA shuffling for randomised heterologous and homogenous 3' and 5' primers for construction of DNA libraries for generation of more desirable mutants
CN108060191B (en) * 2017-11-07 2021-05-04 深圳华大智造科技股份有限公司 Method for adding adaptor to double-stranded nucleic acid fragment, library construction method and kit
CN108410970A (en) * 2018-03-12 2018-08-17 博奥生物集团有限公司 A kind of detection method and kit of unicellular genome copies number variation
CN112176028B (en) * 2019-07-05 2024-04-16 深圳华大生命科学研究院 Rapid WGS library construction method based on endonuclease

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103827318A (en) * 2011-05-27 2014-05-28 生命技术公司 Methods for manipulating biomolecules
CN107217308A (en) * 2017-06-21 2017-09-29 北京贝瑞和康生物技术股份有限公司 A kind of sequencing library construction method and kit for being used to detect chromosome copies number variation
US20190153435A1 (en) * 2017-11-22 2019-05-23 New England Biolabs, Inc. Method for Fragmenting DNA by Nick Translation
WO2021027810A1 (en) * 2019-08-12 2021-02-18 深圳市真迈生物科技有限公司 Nucleic acid sample processing method, sequencing method and kit
WO2022001149A1 (en) * 2020-06-28 2022-01-06 江苏康科斯医疗科技有限公司 Enzyme reaction solution for constructing sequencing library and use thereof
CN113337487A (en) * 2021-02-09 2021-09-03 南京诺唯赞生物科技股份有限公司 Enzyme composition for nucleic acid fragmentation and application thereof
CN114197061A (en) * 2022-02-17 2022-03-18 北京贝瑞和康生物技术有限公司 Method and kit for constructing sequencing library for detecting chromosome copy number variation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CAO BO, WU XIAOLIN, ZHOU JIELIANG, WU HANG, LIU LILI, ZHANG QINGHUA, DEMOTT MICHAEL S, GU CHEN, WANG LIANRONG, YOU DELIN, DEDON PE: "Nick-seq for single-nucleotide resolution genomic maps of DNA modifications and damage", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, GB, vol. 48, no. 12, 9 July 2020 (2020-07-09), GB , pages 6715 - 6725, XP093085471, ISSN: 0305-1048, DOI: 10.1093/nar/gkaa473 *

Also Published As

Publication number Publication date
CN114197061A (en) 2022-03-18

Similar Documents

Publication Publication Date Title
WO2021013244A1 (en) Method for constructing capture library and kit
US20240150828A1 (en) Sequencing methods and compositions for prenatal diagnoses
EP3388519B1 (en) Vesicular adaptor and uses thereof in nucleic acid library construction and sequencing
US20210246498A9 (en) Human identification using a panel of snps
JP7232643B2 (en) Deep sequencing profiling of tumors
WO2015081229A2 (en) Selective amplification of nucleic acid sequences
WO2021052310A1 (en) Dna library construction method
JP2020529219A (en) Methods and kits for constructing sequencing libraries for use in the detection of chromosomal copy number variation
WO2023155847A1 (en) Method and kit for constructing sequencing library for detecting chromosome copy number variation
JP2023519782A (en) Methods of targeted sequencing
US20210102246A1 (en) Genetic test for detecting congenital adrenal hyperplasia
WO2023036271A1 (en) Method for constructing capture library having high test performance, and kit
WO2021253372A1 (en) High-compatibility pcr-free library building and sequencing method
AU2015203579A1 (en) Sequencing methods and compositions for prenatal diagnoses
WO2014086037A1 (en) Method for constructing nucleic acid sequencing library and applications thereof
CN114032287A (en) DNA methylation sequencing library and construction method and detection method thereof
WO2018073323A1 (en) Method for complete, uniform and specific amplification of ultra-low amounts of input dna
CN113293200B (en) Method for reducing or eliminating amplification product pollution in next generation sequencing and application
WO2023116373A1 (en) Method for generating population of labeled nucleic acid molecules and kit for the method
US20200291453A1 (en) Amplicon generation
TWI837127B (en) Single tube bead-based dna co-barcoding for accurate and cost-effective sequencing, haplotyping, and assembly
WO2023240611A1 (en) Library construction and sequencing method for single-stranded nucleic acid cyclic library
US20220177873A1 (en) Isolation and immobilization of nucleic acids and uses thereof
WO2020113569A1 (en) Method for sequencing long fragment nucleic acid
Wilson et al. High-Fidelity Nanopore Sequencing of Ultra-Short DNA Sequences

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23755848

Country of ref document: EP

Kind code of ref document: A1